Synopsys's cash and equivalents was $2.89 billion for fiscal year 2025 (the twelve months to 31 Oct 2025), down 25.9% from fiscal 2024.
In the third quarter of fiscal 2026 (the three months to 31 Jul 2026) it was $3.61 billion, up 42.7% from a year earlier.
From Synopsys's annual and quarterly reports, compiled and checked by AapWire. Latest report filed 26 Aug 2026.
Fiscal 2025
$2.89B
−25.9%
Q3 FY2026
$3.61B
+42.7% on a year
Growth over 9 years
+12.8%
a year, FY 2016–FY 2025
Cash and equivalents by fiscal year
Change on the year before, under each year. From FY 2016 to FY 2025, Synopsys's cash and equivalents went from $977 million to $2.89 billion, a compound annual change of +12.8%; the highest was $3.90 billion in FY 2024.
Synopsys cash and equivalents, fiscal years
Period
FY 2016
FY 2017
FY 2018
FY 2019
FY 2020
FY 2021
FY 2022
FY 2023
FY 2024
FY 2025
Cash and equivalents
$977M
$1.05B
$723M
$729M
$1.24B
$1.43B
$1.42B
$1.43B
$3.90B
$2.89B
Period end
31 Oct 2016
31 Oct 2017
31 Oct 2018
31 Oct 2019
31 Oct 2020
31 Oct 2021
31 Oct 2022
31 Oct 2023
31 Oct 2024
31 Oct 2025
Cash and equivalents by quarter
The last eight fiscal quarters. Each is compared with the same quarter a year earlier on the company's page.
Synopsys cash and equivalents, fiscal quarters
Period
Q4 FY2024
Q1 FY2025
Q2 FY2025
Q3 FY2025
Q4 FY2025
Q1 FY2026
Q2 FY2026
Q3 FY2026
Cash and equivalents
$3.90B
$3.65B
$14.1B
$2.53B
$2.89B
$2.13B
$2.41B
$3.61B
Period end
31 Oct 2024
31 Jan 2025
30 Apr 2025
31 Jul 2025
31 Oct 2025
31 Jan 2026
30 Apr 2026
31 Jul 2026
How cash and equivalents is measured
Cash and equivalents is the cash the company holds at the end of the period and the investments it can turn into cash within three months. Figures are read from the report the company filed and checked against accounting identities; one that does not pass is left blank rather than estimated. See data and methodology.
Synopsys's other figures
Cash and equivalents of comparable companies
Everything on SNPS, in the terminal.
Twenty years of history, operating KPIs and segments, guidance against results, valuation, insiders and holders, charts and alerts.